Suresh S. Ramalingam, MD, Appointed Executive Director of the Winship Cancer Institute and Associate Vice-President for Cancer at the Woodruff Health Sciences Center of Emory University

Surgical Outcomes of CheckMate816 Support Use of Neoadjuvant Nivolumab Plus Chemotherapy for NSCLC

VIOLET Data Establishes VATS as Standard for Early-Stage Resectable NSCLC

High-Dose Once-Daily Thoracic Radiotherapy Did Not Improve OS in Limited Stage SCLC

Single Institution’s Experience: SABR Shows Outstanding OS vs. VATS in Patients with Early-Stage NSCLC

IMpower010: Adjuvant Atezolizumab Improved DFS in PD-L1 Expressing Stage II-IIIA NSCLC

Wally Curran Departs Directorship at Emory for a Lead Role with GenesisCare

Dr. Anne-Marie Dingemans Leads EORTC’s Lung Cancer Group

Dr. Marina Garassino Accepts Professorship at University of Chicago

Leveraging Lung Cancer Screening Scans to Detect Early Interstitial and Obstructive Lung Disease

Low-Dose CT Screening with Guidance from Biomarkers May be Beneficial for Some Patients Who Have Never Smoked

Strategies for Implementing Lung Cancer Screening Programs in Low-Middle Income Countries